FLT3 mutation + NRAS mutation
|
AML
|
FLT3 mutation + NRAS mutation
|
AML
|
cytarabine Resistant: C3 – Early Trials
|
cytarabine Resistant: C3 – Early Trials
|
FLT3 mutation + NRAS mutation
|
AML
|
FLT3 mutation + NRAS mutation
|
AML
|
gilteritinib Sensitive: C3 – Early Trials
|
gilteritinib Sensitive: C3 – Early Trials
|